EGFR and non-small cell lung carcinoma: This report described the many studies on the efficacy of EGFR-TKIs in patients with EGFR-mutant NSCLC with coexisting intra-EGFR or other gene mutations and molecular markers that may predict EGFR-TKI efficacy.